| Financial Year |
March 31 2023 |
| Monetary Funds |
16,718,128.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
138,252,387.81 |
| Advances to Suppliers |
5,086,945.65 |
| Other Receivables |
3,760,176.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,071,669.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,162,507.52 |
| Total Current Assets |
213,999,236.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,880.81 |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,550,909.51 |
| Fixed Assetes |
391,553.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,489.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,986,747.25 |
| Other Non-Current Assets |
5,864,940.00 |
| Sub-Total of Non-Current Assets |
19,839,521.24 |
| Total Assets |
233,838,758.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
144,927,140.58 |
| Accounts Received In Advance |
1,575,000.00 |
| Employee Compensation Payable |
7,151,539.96 |
| Taxes Payable |
1,088,554.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,505,583.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
18,013,626.52 |
| Sub-Total of Current Liabilities |
194,736,454.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,357,527.56 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,357,527.56 |
| Total Liabilities |
213,093,982.48 |
| Paid-In Capital(Or Share Stock) |
200,506,500.00 |
| Capital Surplus |
838,781,867.02 |
| Surplus Reserve |
25,567,706.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,043,955,193.34 |
| Minority Stockholder's Interest |
-156,104.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,900,879.85 |
| Owner's Equity（Stockholder's Equity） |
20,744,775.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
233,838,758.02 |
